mix overal set well
report mix result revenu ep fall shi estim
howev exclud healthcar product recal revenu growth would improv
slightli ep would met estim initi ep guidanc met
consensu would better without estim drag
coronaviru impact ecl china busi unexpect pension cost
headwind underli oper profit growth impli guidanc remain
strong continu see qualiti defens growth stori
compound earn doubl digit rate time trim estim
coronaviru pension headwind rais po
ep account strong underli profit growth higher peer
revenu rose organ cc basi
estim healthcar product recal weaker us drill energi
spun larg blame growth would ex issu adjust
oper margin expand y/i adjust ep rose
our/consensu estim though would met consensu
exclud product recal impact
introduc adjust ep guidanc rang y/i
bracket consensu estim includ unexpect
headwind includ neg impact pension oblig fx
coronaviru exclud item midpoint would solidli
exceed consensu impli underli growth call
adjust ep y/i our/consensu estim
due part coronaviru impact
full definit iqmethod sm measur see page
bofa secur seek busi issuer cover research report
result investor awar firm may conflict interest could
affect object report investor consid report singl
factor make invest decis
refer import disclosur page analyst certif page price
object basis/risk page
net dbt
return capit employ
return equiti
global leader water clean
energi product servic provid
chemic on-site servic custom
food health care energi hospit industri
gener sale across
strong franchis durabl
competit advantag recur defens
growth model healthi long-term prospect
back solid organ revenu growth
strengthen margin outlook driven price
big cost reduct program see posit
momentum forecast
ep compound-annual-growth-rate expect drive
iqmethod sm qualiti earn
net incom cont oper
chang work capit
full definit iqmethod sm measur see page
revenu growth weaken sequenti team upbeat
organ cc revenu rose bp deceler
estim growth weaker perform driven sequenti
deterior under-perform vs estim growth institut vs
vs servic vs
global industri improv slightli vs in-lin estim
compani blame healthcar product recal primari drag weaker us
energi drill activ time new busi roll-out pest also mention
healthcar revenu within institut declin y/i would grown ex
recal total institut would stronger healthcar recal
result bacteri contamin european plant taken
offlin back on-line mid-decemb plant reactiv decemb
though manag expect residu cost flow
last quarter manag gave updat compani strategi focus
new busi win less price focu prior
month face raw materi price inflat compani state transit
go well cite strong book second consecut quarter ecolab
expect rebuild revenu growth next quarter time
issu normal new busi flow sale typic take
quarter depend servic
exhibit adjust oper margin y/i chang bp
margin also weaker expect
healthcar recal also hurt margin rose solid bp y/i though fell
short bp estim industri bp bp strong
though partial off-set margin declin institut bp
despit weaker institut margin finish strong full year
margin expans bp driven solid revenu growth improv
price moder raw build benefit compani cost effici
effort look forward see strong margin outlook compani build
save effici program like combin acceler revenu growth
stabl raw environ
adjust ep rose our/consensu estim
though would met consensu exclud product recal impact
impli earn growth doubl digit y/i
introduc adjust ep guidanc rang y/i
bracket consensu estim includ unexpect
headwind includ neg impact pension oblig fx
estim drag coronaviru compani china oper
exclud item midpoint would solidli exceed consensu
in-lin prior estim would y/i growth
manag expect revenu growth ramp year new book work
way revenu see modest price
call adjust ep y/i
our/consensu estim due part coronaviru impact
expect team non-specif impact viru beyond
first quarter mani unknown current howev viru
neg impact institut hospit restaur industri segment
chines market
guidanc prior estim encourag strong
underli oper earn growth strong margin outlook compani
expect see revenu acceler especi beyond meaning stronger
margin healthi cash flow
trim estim coronaviru pension impact po
updat model reduc estim incorpor neg
impact coronaviru impact ecolab chines busi addit
higher pension expens amid lower interest rate adjust
ep estim fall respect howev
increas po base adjust price-to-earnings multipl
ep prior multipl reflect strengthen
oper earn outlook ex st coronaviru impact higher peer multipl
especi defens grower
sale
provis tax
exhibit global industri segment revenu oper profit margin growth
y/i margin chang bp
ecolab global industri segment revenu rose organ cc
basi similar last quarter in-lin estim growth mix
across sub-seg y/i life scienc best
perform oper margin rose nice bp y/i bp
estim team cite price cost save initi solid profit gain
exhibit global institut segment revenu oper profit margin growth
y/i margin chang bp
ecolab global institut segment revenu rose organ cc
basi deceler last quarter also estim
growth gener good exit lower margin busi institut
modest drag healthcar unit saw product recal caus busi
declin result recal oper margin fell bp y/i
significantli estim
exhibit global energi segment revenu oper profit margin growth
y/i margin chang bp
ecolab global energi segment revenu declin organ cc basi
slight deceler championx sale declin quarter
owe signific decreas well stimul busi north american
activ remain weak off-set solid product growth downstream
keep post spin rose moder howev oper margin rose
bp y/i nice estim bp expans
exhibit servic segment revenu oper profit margin growth
y/i margin chang bp
servic segment revenu rose organ cc basi
steadi deceler last quarter good growth across region
slow time new busi rollout oper margin drop bp
y/i tough comp invest well estim bp
expans
sale
incom tax
provis tax
margin analysi revenu
servic
servic
base price object adjust ep target multipl
histor ntm price-to-earnings reflect strong improv margin
earn growth outlook also higher usual valuat premium current
place defens grower
downsid risk price object sudden increas commod cost
slower end-market trend merger integr risk upsid risk price
object faster expect recoveri segment profit better
expect market share gain potenti accret acquisit
gari bisbe cfa herebi certifi view express research report
accur reflect person view subject secur issuer also
certifi part compens directli indirectli relat
specif recommend view express research report
